#BEGIN_DRUGCARD DB06150

# AHFS_Codes:
Not Available

# ATC_Codes:
J01ED01

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Agribon
Albon
Di-Methox

# CAS_Registry_Number:
122-11-2

# ChEBI_ID:
32161

# Chemical_Formula:
C12H14N4O4S

# Chemical_IUPAC_Name:
4-amino-N-(2,6-dimethoxypyrimidin-4-yl)benzene-1-sulfonamide

# Chemical_Structure:
Not Available

# Creation_Date:
2007-12-10 05:36:16 -0700

# DPD_Drug_ID_Number:
Not Available

# Description:
Sulfadimethoxine (trade name Di-Methox, Albon) is a sulfonamide antibiotic. Sulfadimethoxine is used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Sulfadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid.

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Methotrexate	The sulfamide increases the toxicity of methotrexate

# Drug_Reference:
Not Available

# Drug_Type:
Approved
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
1.63

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
343 mg/L

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Sulfadimethoxine

# HET_ID:
Not Available

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)

# InChI_Key:
InChIKey=ZZORFUFYDOWNEF-UHFFFAOYSA-N

# Indication:
For use in the treatment of infections.

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
6151

# Mechanism_Of_Action:
Not Available

# Melting_Point:
203.5 Â°C

# Molecular_Weight_Avg:
310.329

# Molecular_Weight_Mono:
310.073575646

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
PA165958357

# Pharmacology:
Sulfadimethoxine has been shown to be effective against streptococci, klebsiella, proteus, shigella, staphylococci, escherichia, and salmonella.

# Predicted_LogP_Hydrophobicity:
1.08

# Predicted_LogS:
-3

# Predicted_Water_Solubility:
2.78e-01 g/l

# Primary_Accession_No:
DB06150

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5323

# PubChem_Substance_ID:
99443234

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Sulphadimethoxine

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:24:30 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Sulfadimethoxine

# pKa_Isoelectric_Point:
Not Available

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
CYP2C9

# Phase_1_Metabolizing_Enzyme_1_ID:
4757

# Phase_1_Metabolizing_Enzyme_1_Name:
Cytochrome P450 2C9

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Cytochrome P450 2C9
MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKV
YGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKW
KEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS
IIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFM
KSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTE
TTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYID
LLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFK
KSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVP
PFYQLCFIPV

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P11712

#END_DRUGCARD DB06150
